High concentration antibody formulations

Details for Australian Patent Application No. 2012201364 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Zhou, Xiao-Hong; Wang, Yi

Agent Shelston IP

Pub. Number AU-A-2012201364

Priority 61/450,334 08.03.11 US

Filing date 7 March 2012

Wipo publication date 20 September 2012

International Classifications

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/00 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

22 March 2012 Complete Application Filed

  Priority application(s): 61/450,334 08.03.11 US

20 September 2012 Application Open to Public Inspection

  Published as AU-A-2012201364

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201365-A window winder

2012201363-Method and plant for flue gas denoxing